272 related articles for article (PubMed ID: 32340551)
1. Natural products may interfere with SARS-CoV-2 attachment to the host cell.
Elfiky AA
J Biomol Struct Dyn; 2021 Jun; 39(9):3194-3203. PubMed ID: 32340551
[TBL] [Abstract][Full Text] [Related]
2. Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective.
Elshemey WM; Elfiky AA; Ibrahim IM; Elgohary AM
Comput Biol Med; 2022 Jun; 145():105478. PubMed ID: 35421790
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 spike-host cell receptor GRP78 binding site prediction.
Ibrahim IM; Abdelmalek DH; Elshahat ME; Elfiky AA
J Infect; 2020 May; 80(5):554-562. PubMed ID: 32169481
[TBL] [Abstract][Full Text] [Related]
4. New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19.
Li T; Fu J; Cheng J; Elfiky AA; Wei C; Fu J
Front Immunol; 2023; 14():1166680. PubMed ID: 37275848
[TBL] [Abstract][Full Text] [Related]
5. In silico targeting of SARS-CoV-2 spike receptor-binding domain from different variants with chaga mushroom terpenoids.
Amin FG; Elfiky AA; Nassar AM
J Biomol Struct Dyn; 2024; 42(2):1079-1087. PubMed ID: 37042960
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
7. Stilbene-based natural compounds as promising drug candidates against COVID-19.
Wahedi HM; Ahmad S; Abbasi SW
J Biomol Struct Dyn; 2021 Jun; 39(9):3225-3234. PubMed ID: 32345140
[TBL] [Abstract][Full Text] [Related]
8. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses.
Elfiky AA
Front Pharmacol; 2020; 11():577467. PubMed ID: 33362542
[TBL] [Abstract][Full Text] [Related]
10. An
Sinha SK; Shakya A; Prasad SK; Singh S; Gurav NS; Prasad RS; Gurav SS
J Biomol Struct Dyn; 2021 Jun; 39(9):3244-3255. PubMed ID: 32345124
[TBL] [Abstract][Full Text] [Related]
11. Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations.
Sasidharan S; Selvaraj C; Singh SK; Dubey VK; Kumar S; Fialho AM; Saudagar P
J Biomol Struct Dyn; 2021 Sep; 39(15):5706-5721. PubMed ID: 32619162
[TBL] [Abstract][Full Text] [Related]
12. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.
Das S; Sarmah S; Lyndem S; Singha Roy A
J Biomol Struct Dyn; 2021 Jun; 39(9):3347-3357. PubMed ID: 32362245
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
15. Optimization Rules for SARS-CoV-2 M
Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus glycoprotein GP1-host cell-surface HSPA5 binding site prediction.
Elfiky AA
Cell Stress Chaperones; 2020 May; 25(3):541-548. PubMed ID: 32291698
[TBL] [Abstract][Full Text] [Related]
17. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL
Gyebi GA; Ogunro OB; Adegunloye AP; Ogunyemi OM; Afolabi SO
J Biomol Struct Dyn; 2021 Jun; 39(9):3396-3408. PubMed ID: 32367767
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
19. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
Romeo A; Iacovelli F; Falconi M
Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
[TBL] [Abstract][Full Text] [Related]
20. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2
Khan SA; Zia K; Ashraf S; Uddin R; Ul-Haq Z
J Biomol Struct Dyn; 2021 Apr; 39(7):2607-2616. PubMed ID: 32238094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
